Silicone granuloma formation associated with dermal injection Leo L. Wang, MS; William W. Thomas, MD; Cherie M. Ditre, MD; Oren Friedman, MD A 63-year old woman presented from an outside dermatologist for management of significantly deforming and painful facial silicone granulomas. She initially had undergone injection of what she had been told was "Restylane" 5 years earlier. The injection was performed as part of an "injectable party" in a private apartment of her acquaintance in Philadelphia. She had received injections to her upper lip, melolabial folds, and glabella. Subsequently, she reported a gradual onset of nodularity, swelling, and aesthetic distortion of her appearance at the injection sites in the 2 years before presentation to our facility.
The patient also experienced pain and tenderness in the regions of the injected silicone that had developed over the course of the prior 2 years, and the deformities progressed from subtle to obvious over the same time. Before her presentation to our institution, an ultrasound and computed tomography (CT) scan had been obtained, which suggested that silicone was embedded in the patient's tissues (figure 1, A). Her medical history was remarkable for osteoporosis, endometriosis, and degenerative joint disease. She had no known mental health diagnosis or concern for body dysmorphic disorder.
The patient had undergone fine-needle aspiration by the referring physician, with the cytology indicating multinucleated histiocytes and fibroepithelial groups, compatible with a reactive/inflammatory process. Upon her presentation to our institution, photographs were obtained ( figure 1, B) and a trial of triamcinolone 0.3 ml was injected to a lower lip nodule to assess for efficacy. The patient did not have any noticeable reduction in size or nodularity, and she elected for direct excision.
Under monitored anesthesia care with sedation, the patient underwent direct excision of the lip and glabellar nodules. The lip nodules were excised with an O-T closure technique, and the glabellar nodules were removed through a vertical rhytid incision; the largest of the excised specimens measured 3.8 × 2.3 × 1.6 cm (figure 2). Excision of the glabellar lesions left a significant volume defect, and bilateral procerus and corrugator muscle flaps were brought medially for improved contour. The incisions were closed, and a glabellar pressure dressing was applied.
On postoperative day 3, a 3-ml sterile glabellar hematoma was aspirated from the dead space that had resulted from removal of the large mass of silicone, and a compressive dressing was reapplied. The patient was maintained subsequently on 7 days of cephalexin. Upon questioning, the patient admitted to taking ibuprofen every 6 hours postoperatively despite receiving instructions to avoid nonsteroidal anti-inflammatory medications. Upon follow-up 1 week later, she was heal-FACIAL PLASTIC SURGERY CLINIC ing well with no further hematoma. At the last-followup on postoperative day 30, photographs were taken. A final before-and-after comparison is shown in figure 3 . We caution physicians on the use of silicone fillers which, for all their advantages, are associated with significant long-term risks. Injectable fillers have become extremely popular over the past decade and are considered a useful addition to the armamentarium of the cosmetic medical provider. [1] [2] [3] They allow a minimally invasive approach to facial reconstruction, and their use has become widespread. 4 Due to their minimally invasive nature, patients and providers approach injectables with the notion that they are low-risk procedures. In this article, we highlight one of the significantly deforming complications that may result from the use of injectable silicone fillers, in hopes of increasing awareness of the problem and minimizing the potential harm to patients. 
